IPO

With a clear FDA path for its breakthrough drug, Praxis is set to disrupt the stagnant, multi-billion-dollar essential tremor market.

Virax secured a $5M runway for its Long COVID diagnostics, but the deal's terms reveal a high-stakes gamble involving significant shareholder dilution.

With $15M in new funding and seasoned mining execs on board, Getty Copper is now debt-free and poised to unlock the potential of its vast copper assets.

Gartner's inaugural 4PL Magic Quadrant names Redwood a Visionary, highlighting how tech-driven logistics are reshaping healthcare supply chain resilience.

Endeavour Silver's massive convertible note offering slashes debt and funds its giant Pitarrilla project. A savvy move or a dilution risk for investors?

How Winemaker of the Year Jesse Katz blends record-setting sales, historic vineyards, and philanthropy to disrupt the ultra-premium wine market.

Facing a 70% stock decline, High Roller Technologies is shaking up its marketing. Can two industry veterans redefine the user experience and win the iGaming wars?

A struggling gaming firm merges with Dogecoin's commercial arm in a $1.09B deal. Is it a visionary pivot or a reverse takeover built on crypto hype?

A routine UK regulatory filing has exposed Arrowstreet Capital's quiet 1.22% stake in the $1.44B American Axle-Dowlais merger, signaling a major quant fund's bet.

A $57.5M investment signals a major shift as a top logistics player expands to Texas, tapping into Port Houston's booming refrigerated cargo market.

High internet penetration and modern regulations are creating a fertile digital market, with Expanse Studios' recent expansion showing the way.

Amid soaring uranium prices, Foremost Clean Energy deploys advanced geophysics in the Athabasca Basin. A deep dive into the strategy behind the search.

Lion Group is diversifying its crypto-heavy treasury with Bitcoin. Is this a savvy move in a cool market or a high-stakes bet for a volatile company?